As General Manager of Cell and Gene Therapy, Mr. Poltilove has overall P&L responsibility for the Thermo Fisher business segment, including long-range product line strategy, investment, and day-to-day business operations. Previously, he led a $350M business segment of Cell Biology reagents and instrumentation. Prior to joining Thermo Fisher, Mr. Poltilove served as the Director of Revenue Strategy & Operations for the Corporate Executive Board and held several roles with Johnson & Johnson. He holds Bachelor’s degrees in Chemical Engineering and Economics from MIT and an M.B.A. from Northwestern University.